Cargando…

Atripla™ – HIV therapy in one pill

In July 2006 Atripla™ was approved by the US Food and Drug Administration (FDA), combining the active ingredients of one NNRTI and two NRTIs. Atripla™ is the first “one-pill-daily” regimen licensed for the treatment of HIV-1 infection in patients older than 18 years. H was licensed in Europe in Dece...

Descripción completa

Detalles Bibliográficos
Autores principales: Julg, Boris, Bogner, Johannes R
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500249/
https://www.ncbi.nlm.nih.gov/pubmed/18827852